SCHEMBL4786909

SCHEMBL4786909

CC(C)(C)OC(=O)CC(NC(=O)c1cnc2c([N+](=O)[O-])cccc2c1N1CCN(C(=O)OC(C)(C)C)CC1)C(O)CF

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.39
LMNA P02545 5/20 0.37
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
PTPN11 Q06124 1/20 0.36
BCL2 P10415 1/20 0.36
BCL2L1 Q07817 1/20 0.36
ACHE P22303 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BACE1 P56817 1/20 0.34
MAPK8 P45983 1/20 0.34
USP2 O75604 1/20 0.33
TP53 P04637 1/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4742558 0.89 USP2 (0.44) METLMNAMAPTPTPN11ACHE
SCHEMBL4743406 0.88 MET (0.39) METLMNAMAPTALDH1A1PTPN11
SCHEMBL4742589 0.85 MET (0.44) METLMNAMAPTALDH1A1PTPN11
SCHEMBL4742105 0.80 THRB (0.45) METMAPTPTPN11SMN1; SMN2
SCHEMBL4742147 0.80 LMNA (0.48) METLMNAMAPTALDH1A1PTPN11
SCHEMBL4742099 0.78 LMNA (0.55) LMNAMAPTALDH1A1SMN1; SMN2USP2
SCHEMBL4743037 0.77 MAPT (0.40) LMNAMAPTPTPN11ACHEBACE1
SCHEMBL4742621 0.77 USP2 (0.45) METLMNAMAPTPTPN11ACHE
SCHEMBL4739339 0.73 MET (0.46) METLMNAMAPTALDH1A1PTPN11
SCHEMBL4739351 0.70 MAPK1 (0.35) METLMNAMAPTALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008093940-A1 QUINOLINE DERIVATIVES AS CASPASE-3 INHIBITOR, PREPARATION PROCESS FOR THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 2008-08-07 WO disclosed